Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.
Open | $127.530 |
Close | $128.770 |
Volume / Avg. | 1.236M / 835.338K |
Day Range | 125.620 - 131.460 |
52 Wk Range | 55.250 - 159.890 |
Market Cap | $12.169B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 5.09% |
Days to Cover | 7.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sarepta Therapeutics (NASDAQ: SRPT) through any online brokerage.
Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Sarepta Therapeutics (NASDAQ: SRPT) was reported by UBS on Friday, March 1, 2024. The analyst firm set a price target for 167.00 expecting SRPT to rise to within 12 months (a possible 29.69% upside). 60 analyst firms have reported ratings in the last year.
The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $128.77 last updated April 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Sarepta Therapeutics.
Sarepta Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Sarepta Therapeutics.
Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.